Start trading now on Poste Italiane

Walgreens posts Q3 2023 revenue growth, misses EPS estimates

|

©

Walgreens Boots Alliance (NASDAQ:) reported its Q3 2023 financial results on Thursday, revealing a 9.2% year-over-year (YoY) increase in revenue to $35.42 billion, surpassing estimates from Zacks Consensus Estimate. However, the company’s earnings per share (EPS) fell to $0.67 from $0.80 YoY, missing the EPS estimates.

The company also reported a higher number of locations than anticipated, ending with 8,720 locations compared to the estimated 8,689. Additionally, Walgreens saw a significant increase in comparable sales for U.S. Retail Pharmacy – Pharmacy at 9.2%, significantly higher than the estimated 0.6%.

Revenues across various segments showed varied performance against estimates and YoY changes. The U.S. Retail Pharmacy segment generated $21.13 billion, while revenues from the U.S. Retail Pharmacy- Retail and International – Wholesale segments amounted to $6.54 billion and $2.90 billion respectively.

Despite these results, Walgreens is currently ranked #4 (Sell) by Zacks, indicating potential underperformance in the near term. This ranking comes even as its shares returned +3.2% over the past month, outperforming the Zacks composite’s -2.4% change.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Previous Post
Combat veteran is top contender to replace China’s missing defence minister
Next Post
Dow futures steady as CPI snaps stock rally

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Invest on crypto with Gianluca Vacchi project and start making money now
Win money trading on Amazon
INVEST NOW
keyboard_arrow_up